Emergent BioSolutions News
Most Popular Emergent BioSolutions Story
Abbott nixes cancer drug alliance with Emergent BioSolutions
Emergent BioSolutions ($EBS) has suffered a setback in its campaign to expand into cancer drug development. Abbott Labs ($ABT) has decided to dump a partnership with Emergent on the development of Read more...
Latest Headlines
- December 29, 2011
- August 13, 2010
- July 19, 2010
- December 9, 2009
- November 19, 2009
- January 7, 2009
- September 26, 2008
- September 4, 2008
- July 30, 2008
- July 10, 2008
- June 16, 2008
- May 27, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
